• Dihydroethidium (DHE): Reliable Superoxide Measurement in Ce

  2026-05-22

  This article provides an evidence-based, scenario-driven guide to overcoming common pitfalls in oxidative stress detection using Dihydroethidium (DHE, SKU C3807). From conceptual principles to vendor selection, we address workflow challenges and showcase how high-purity DHE from APExBIO ensures reproducibility, sensitivity, and data fidelity for intracellular reactive oxygen species assays.

• Dual FOXO3-Mediated Metabolic Inhibition in Hepatocellular C

  2026-05-22

  This study uncovers how activation of FOXO3 transcriptionally represses YAP, resulting in simultaneous inhibition of glycolysis and glutaminolysis in hepatocellular carcinoma (HCC). The findings reveal a critical metabolic vulnerability and propose the FOXO3/YAP axis as a promising therapeutic target in HCC.

• Bacillus Strains and Media Shape γ-Glutamyl Peptide Producti

  2026-05-21

  This study systematically evaluates how Bacillus strain selection and growth medium composition affect the generation of γ-glutamyl peptides, including key dipeptides and glutathione. The findings reveal that medium composition has a stronger influence than strain type, with implications for both food biotechnology and glutathione metabolism research.

• MLN2238: Precision Proteasome β5 Subunit Inhibitor Workflows

  2026-05-21

  MLN2238 sets a new benchmark for chymotrypsin-like proteasome inhibition, enabling robust workflows in oncology and proteostasis research. Explore step-by-step protocols, troubleshooting tactics, and translational insights from the latest reference study to maximize assay success and drive discoveries in drug resistance and neurodegeneration.

• SU5416 (Semaxanib): Applied Protocols for Angiogenesis Inhib

  2026-05-20

  SU5416 (Semaxanib) is a validated, selective VEGFR2 inhibitor that empowers researchers to precisely dissect angiogenesis and immune modulation in cancer, vascular, and immunological models. This guide delivers stepwise protocol enhancements, troubleshooting strategies, and translational context—bridging key findings from biomarker-driven PAH research to optimized experimental workflows.

• Neticonazole Hydrochloride: Dual-Action Imidazole Antifungal

  2026-05-20

  Neticonazole Hydrochloride uniquely bridges antifungal and oncology research, enabling streamlined experimental protocols for both fungal inhibition and colorectal cancer models. Its dual mechanisms and robust solubility empower reliable workflows, while recent advances in nanoparticle delivery position it at the forefront of translational therapeutics.

• L1023 Anti-Cancer Compound Library: Streamlining High-Throug

  2026-05-19

  The L1023 Anti-Cancer Compound Library empowers researchers with 1164 curated, bioactive molecules for rapid, pathway-centric cancer drug discovery. Its high-throughput-ready format and proven selectivity accelerate experimental workflows, supporting innovative screening strategies and robust troubleshooting in cancer research.

• Alternariol: Mechanisms, Hepatotoxicity, and Research Integr

  2026-05-19

  Alternariol (AOH) is a fungal mycotoxin with significant roles in mycotoxin research and hepatotoxicity modeling. Its molecular actions span cytochrome P450 metabolism, apoptosis induction, and hepatic stellate cell activation, establishing it as a core probe for toxin mechanism and risk assessment studies.

• 2-Hydroxypropyl-β-cyclodextrin: Solubility Excipient in Rese

  2026-05-18

  2-Hydroxypropyl-β-cyclodextrin addresses the persistent challenge of dissolving poorly water-soluble, hydrophobic compounds—especially those with aromatic or phenyl groups—by forming inclusion complexes that enhance aqueous solubility. Its use is best confined to pharmaceutical and biochemical research workflows focused on solubility improvement; broader or therapeutic applications are not supported by the current product specification or validated workflows.

• Beclin1 Deficiency Mitigates DOX-Induced Liver Ferroptosis

  2026-05-18

  Ye et al. (2026) reveal that Beclin1 deficiency alleviates doxorubicin-induced liver injury by inhibiting both ferroptosis and autophagy, with DHODH identified as a protective downstream target. These findings clarify the mechanistic link between Beclin1, oxidative stress, and ferroptotic cell death, offering translational insight for hepatic protection in chemotherapy contexts.

• Tunicamycin: Precision N-Glycosylation Inhibitor for ER Stre

  2026-05-17

  Tunicamycin stands as the gold-standard N-glycosylation inhibitor, enabling precise induction of ER stress and robust suppression of macrophage inflammation. This article delivers actionable, evidence-backed protocols and troubleshooting guidance for maximizing experimental reproducibility and insight in glycosylation and unfolded protein response research.

• LMO2–LDB1 Complex Drives AML Progression: Mechanistic Insigh

  2026-05-16

  This study elucidates how the interaction between LMO2 and LDB1 supports acute myeloid leukemia (AML) cell proliferation and survival. By dissecting the molecular and functional consequences of disrupting this complex, the research identifies the LMO2/LDB1 axis as a potential therapeutic target for AML intervention.

• Mitomycin C: Applied Workflows in Antitumor Antibiotic Resea

  2026-05-15

  Mitomycin C stands out as a gold-standard antitumor antibiotic, enabling robust apoptosis signaling research and precise DNA replication inhibition across diverse cancer models. This guide distills experimental workflows, troubleshooting strategies, and evidence-based enhancements to maximize data integrity and reproducibility with APExBIO's Mitomycin C.

• AZ505 SMYD2 Inhibitor: Elevating Epigenetic and Oncology Res

  2026-05-15

  AZ505, a potent and selective SMYD2 inhibitor from APExBIO, empowers researchers to dissect histone methylation with high specificity, driving advances in cancer biology and renal fibrosis modeling. This guide translates cutting-edge findings into actionable workflows, protocol enhancements, and troubleshooting strategies for reproducible and impactful results.

• Senolytic Discovery via Machine Learning: New Approaches and

  2026-05-14

  The referenced study innovatively applies machine learning to discover novel senolytic agents, identifying ginkgetin, periplocin, and oleandrin as potent candidates. This methodological advance demonstrates how computational techniques can reduce drug screening costs and accelerate senolytic discovery, with significant implications for cancer and aging research.

16247 records 1/1084 page Next 12345 下5页 Last page